Skip to content

13F-HR filed by Artal Group S.A.

Artal Group S.A. filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-09, with 105 holding rows worth $3,843,825,000.

Accession
0001053906-18-000013
Filed
2018-11-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2018

A holdings report, 108 entries on the cover page, a total value of $3,843,825,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,843,825,000 with VALUE read as thousands by filing date, 13F file number 028-15027. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WEIGHT WATCHERS INTL INC948626106COM14,818,300$1,066,769,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK60,240,864$642,770,000thousands by filing date
Goldman Sachs Group,Inc.38141G104COM1,050,000$235,452,000thousands by filing datecall
Bank of America Corp060505104COM4,500,000$132,570,000thousands by filing datecall
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR600,000$103,332,000thousands by filing date
GENERAL MTRS CO COM37045V100Stock3,000,000$101,010,000thousands by filing datecall
Morgan Stanley617446448COM2,000,000$93,140,000thousands by filing datecall
Wells Fargo & Company949746101COM1,500,000$78,840,000thousands by filing datecall
RUBIUS THERAPEUTICS INC78116T103COM2,908,791$69,811,000thousands by filing date
CELGENE CORP151020104COM750,000$67,118,000thousands by filing datecall
SCHOLAR ROCK HLDG CORP80706P103COM2,396,040$61,699,000thousands by filing date
ACCELERON PHARMA INC00434H108COM1,000,000$57,230,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock600,000$52,512,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM800,000$48,768,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM4,000,000$48,360,000thousands by filing date
Bristol-Myers Squibb Company110122108COM750,000$46,560,000thousands by filing datecall
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock1,000,000$41,350,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM500,000$39,030,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM2,190,000$35,675,000thousands by filing date
TESARO INC881569107COM800,000$31,208,000thousands by filing date
ANAPTYSBIO INC032724106COM300,000$29,931,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock1,900,000$28,880,000thousands by filing date
BLUEBIRD BIO INC09609G100COM175,000$25,550,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO1,300,000$25,155,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM300,000$23,136,000thousands by filing date
ZOGENIX INC.98978L204Common Stock400,000$19,840,000thousands by filing date
TESARO INC881569107COM500,000$19,505,000thousands by filing datecall
XENCOR INC98401F105COMMON STOCK500,000$19,485,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM200,000$19,394,000thousands by filing datecall
SPDR SER TR78464A870S&P BIOTECH200,000$19,174,000thousands by filing datecall
Micron Technology,Inc.595112103COM400,000$18,092,000thousands by filing datecall
MEDICINES CO584688105COM600,000$17,946,000thousands by filing datecall
Citigroup Inc.172967424COM250,000$17,935,000thousands by filing datecall
Inflarx NvN44821101COM500,000$17,160,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK500,000$16,480,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS100,000$16,476,000thousands by filing datecall
AUTOLUS THERAPEUTICS PLC SPON05280R100COM500,000$15,335,000thousands by filing date
FIBROGEN INC31572Q808COM250,000$15,188,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM100,000$14,125,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR185,000$14,030,000thousands by filing date
FREEPORT MCMORAN INC CL B35671D857Stock1,000,000$13,920,000thousands by filing datecall
WYNN RESORTS LTD983134107COM100,000$12,706,000thousands by filing datecall
AMERICAN AIRLINES GROUP INC COM02376R102Stock300,000$12,399,000thousands by filing datecall
NEKTAR THERAPEUTICS640268108COM200,000$12,192,000thousands by filing datecall
AMICUS THERAPEUTICS INC03152W109COM1,000,000$12,090,000thousands by filing datecall
MEDICINES CO584688105COM400,000$11,964,000thousands by filing date
Accelerate Diagnostics00430H102COM500,000$11,475,000thousands by filing date
Accelerate Diagnostics00430H102COM500,000$11,475,000thousands by filing datecall
REGENXBIO INC75901B107COM150,000$11,325,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock500,000$10,870,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS65,000$10,709,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock50,000$10,707,000thousands by filing date
SOLID BIOSCIENCES INC COM NEW83422E105Stock225,000$10,616,000thousands by filing date
NIO INC SPON ADS62914V106ADR1,500,000$10,470,000thousands by filing date
AUDENTES THERAPEUTICS INC.05070R104Common Stock250,000$9,898,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM400,000$9,848,000thousands by filing date
ZAFGEN INC98885E103COM800,000$9,352,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM800,000$8,864,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock100,000$8,752,000thousands by filing datecall
SELECTA BIOSCIENCES INC816212104COM561,540$8,732,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM700,000$7,875,000thousands by filing date
CLEMENTIA PHARMACEUTICALS IN185575107COM692,000$7,716,000thousands by filing date
RESTORBIO INC76133L103COM500,000$7,570,000thousands by filing date
REPLIMUNE GROUP INC76029N106COMMON STOCK450,000$7,245,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM400,000$6,640,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM425,000$6,486,000thousands by filing date
SPERO THERAPEUTICS INC84833T103COM600,000$6,306,000thousands by filing date
111 INC68247Q102ADR450,000$6,084,000thousands by filing date
AC IMMUNE SAH00263105SHS750,000$6,000,000thousands by filing date
TRANSLATE BIO INC.89374L104Common Stock600,000$6,000,000thousands by filing date
AGENUS INC00847G705COM NEW2,750,000$5,885,000thousands by filing date
LOGMEIN INC54142L109COMMON STOCK65,000$5,792,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock200,000$5,730,000thousands by filing date
TECTONIC THERAPEUTIC INC COM05455M100Stock100,000$5,187,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM300,000$5,085,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q101COM500,000$5,000,000thousands by filing date
AERPIO PHARMACEUTICALS INC00810B105COM1,558,400$4,815,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock100,000$4,435,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK475,000$4,194,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM300,000$4,182,000thousands by filing date
CHINOOK THERAPEUTICS INC.00739L101Common Stock550,000$4,043,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2200,000$4,026,000thousands by filing date
Y-mAbs Therapeutics Inc984241109Common Stock150,000$3,984,000thousands by filing date
CHIMERIX INC COM16934W106Stock1,000,000$3,890,000thousands by filing date
ELANCO ANIMAL HEALTH INC COM28414H103Stock100,000$3,489,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock250,000$3,300,000thousands by filing date
FLEX LTD ORDY2573F102Stock250,000$3,280,000thousands by filing date
TRICIDA INC89610F101COM100,000$3,055,000thousands by filing date
CONATUS PHARMACEUTICALS INC20600T108COM500,000$2,900,000thousands by filing date
GRITSTONE BIO INC39868T105COM200,000$2,848,000thousands by filing date
SYNLOGIC INC87166L100COM200,000$2,842,000thousands by filing date
MIRAGEN THERAPEUTICS INC60463E103COM500,000$2,790,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock150,000$2,637,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM90,000$2,576,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock400,000$2,420,000thousands by filing date
DIANTHUS THERAPEUTICS INC COM55910K108Stock200,000$2,402,000thousands by filing date
TRANSPORTATION & LOGISTI438083107COM100,000$2,286,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock400,000$2,240,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK110,532$2,040,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK500,000$940,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock150,000$870,000thousands by filing date
UNITY BIOTECHNOLOGY INC91381U101COM50,000$815,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW256,400$759,000thousands by filing date
ATYR PHARMA INC002120103COM500,000$406,000thousands by filing date
ONCOCYTE CORP68235C107COM150,000$375,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001053906-18-000013this filing2018-11-09acceptance time not in the bulk data set